Explore
Trendline
Axsome Therapeutics Reports Strong Financial Growth and New Product Launches in Q2 2026
Axsome Therapeutics Reports Strong Financial Growth and New Product Launches in Q2 2026
Read More
Trendline
Veru Inc. Advances Obesity Treatment with Novo Nordisk Partnership and Reports Q3 2026 Financials
Veru Inc. Advances Obesity Treatment with Novo Nordisk Partnership and Reports Q3 2026 Financials
Read More
Trendline
TG Therapeutics Reports Strong Q2 2026 Earnings with Increased Revenue Guidance
TG Therapeutics Reports Strong Q2 2026 Earnings with Increased Revenue Guidance
Read More
Trendline
Walmart Prepares for Q2 Earnings Report Amid Strong Revenue Growth
Walmart Prepares for Q2 Earnings Report Amid Strong Revenue Growth
Read More
Trendline
SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure
SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure
Read More
Trendline
Reinsurance Group of America Reports Strong Q2 Earnings Driven by Investment Income
Reinsurance Group of America Reports Strong Q2 Earnings Driven by Investment Income
Read More
Trendline
Carter's Reports Strong Q2 2026 Earnings Amid Retail Growth
Carter's Reports Strong Q2 2026 Earnings Amid Retail Growth
Read More
Trendline
Marathon Petroleum Reports Strong Q2 2026 Earnings Amid Stock Volatility
Marathon Petroleum Reports Strong Q2 2026 Earnings Amid Stock Volatility
Read More
Trendline
CLEAR Secure Reports Strong Q2 Earnings with Expansion in Identity Verification Services
CLEAR Secure Reports Strong Q2 Earnings with Expansion in Identity Verification Services
Read More
Trendline
Novo Nordisk Raises 2026 Outlook Amid Strong Q2 Sales Performance
Novo Nordisk Raises 2026 Outlook Amid Strong Q2 Sales Performance
Read More
Trendline
Palantir Technologies Reports Record Q2 Earnings, Raises Full-Year Guidance
Palantir Technologies Reports Record Q2 Earnings, Raises Full-Year Guidance
Read More
Trendline
Palantir Reports Record Q2 Earnings, Sparking Investor Debate Over Valuation
Palantir Reports Record Q2 Earnings, Sparking Investor Debate Over Valuation
Read More